Top Banner
Approach to pediatric retinal disease Ghanbari MD 1391:12:10
24

Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

Dec 22, 2015

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

Approach to pediatric retinal

disease Ghanbari MD

1391:12:10

Page 2: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

LCA

Page 3: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

Infant with normal fundus and low vision• LCA• Stationary night blindness• Achromatopsia • Immue retinopathy

Page 4: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.
Page 5: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.
Page 6: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.
Page 7: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.
Page 8: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.
Page 9: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

Development of the Retina

• The retina develops over a relatively long period of time beginning from the early gestational period through the first years of life.

Page 10: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.
Page 11: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

• Artist’s conception of the perceptual appearance of a visual scene for infants of different ages.

• (a) Newborn, (b) 1 month, (c) 2 months, • (d) 3 months, (e) 6 months,• (f) adult. (copyright by Tony Young;• used with permission)

Page 12: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

Electroretinographic Testing in Infants and Children

• ERG can be recorded as in preterm infants

Page 13: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

Retinopathy of Prematurity (ROP) • Signs and symptoms:• Retinopathy of prematurity (ROP) affects low-birth-weight

premature infants and can lead to blindness; the incidence of ROP has increased, as smaller and younger babies are surviving.

Page 14: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

ROP Risk factors:

• Birth before 32 weeks' gestation, especially before 30 weeks• Birth weight of less than 1500 g, especially less than 1250 g• Possible risk factors include:• Supplemental oxygen, • Hypoxemia, • Hypercarbia, • Concurrent illness.

Page 15: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

Treatment of ROP

• Cryotherapy• Laser surgery • Scleral buckling • Vitrectomy• Anti-VEGF

Page 16: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

Treatment may also be initiated for the following retinal findings:

• Zone 1 ROP - Any stage, with plus disease• Zone 1 ROP - Stage 3, with no plus disease• Zone 2 ROP - Stage 2 or 3, with plus disease

• Treatment should generally be accomplished, when possible, within 72 hours of determination of treatable disease to minimize the risk of retinal detachment.

Page 17: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

• An Updated Study of the Use of Bevacizumab in the Treatment of Patients with Prethreshold Retinopathy of Prematurity in Taiwan.

Page 18: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

• FAMILIAL EXUDATIVE VITREORETINOPATHY

Page 19: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

)

• Persistent Hyperplastic Primary Vitreous (PHPV

Page 20: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

A Language for Retinoblastoma:Guidelines and Standard Operating Procedures

• Retinoblastoma is the most common primary malignant intraocular tumor in children.

Page 21: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

International Classification for Intraocular Retinoblastoma

• Group A

• Small tumors (3 mm across or less) that are confined to the retina and are not near important structures such as the optic disk (where the optic nerve enters the retina) or the foveola (the center of vision).

• Group B

• All other tumors (either larger than 3 mm or small but close to the optic disk or foveola) that are still confined to the retina.

• Group C

• Well-defined tumors with small amounts of spread under the retina (subretinal seeding) or into the gelatinous material that fills the eye (vitreous seeding).

• Group D

• Large or poorly defined tumors with widespread vitreous or subretinal seeding. The retina may have become detached from the back of the eye.

• Group E

• The tumor is very large, extends near the front of the eye, is bleeding or causing glaucoma (high pressure inside the eye), or has other features that mean there is almost no chance the eye can be saved.

Page 22: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

• Shields et al analyzed 249 eyes with retinoblastoma treated with intravenous chemoreduction and found that success was: achieved in of

• Group A 100%, • Group B 93%, • Group C 90%,• Group D 47% eyes. • A later study identified treatment success with intra-arterial

chemotherapy (IAC) in 100% of group C and D eyes, and 33% of group E eyes.

Page 23: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

High-Risk Retinoblastoma Based onInternational Classification ofRetinoblastoma: Analysis of 519Enucleated Eyes

• On the basis of the ICRB, 17% of group D and 24% of group E eyes are at increased risk for metastatic disease. In this study, 8% of patients developed metastasis. There was no metastasis in any patient classified with non–high-risk retinoblastoma.

Page 24: Approach to pediatric retinal disease Ghanbari MD 1391:12:10.

پوزش عرض ضمن

باالی حجم در LECTUERبدلیل نمیباشد پذیر امکان اسالیدها ادامهآموزشی مرکز بصری و سمعی واحد به لطفا ادامه به نیاز صورت

تلفن شماره با یا و مراجعه فیض داخلی 03114476010درمانیتماس حاصل نمائید 392

با تشکر